Status:
RECRUITING
Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries
Lead Sponsor:
Cairo University
Conditions:
Emergence Delirium
Eligibility:
All Genders
2-6 years
Phase:
PHASE1
PHASE2
Brief Summary
The aim of the study is to compare the effectiveness of ketofol for the prevention of emergence delirium in pediatric patients undergoing squint surgery, in comparison to dexmedetomidine.
Detailed Description
To compare the incidence of ED between children who received ketofol with those who received dexmedetomidine. • To compare the adverse effect profile associated with both drugs regarding the effect o...
Eligibility Criteria
Inclusion
- • All pediatric patients aged 2 to 6 years.
- Both sexes.
- ASA physical status I and II.
- Patients undergoing squint surgery.
Exclusion
- • Refusal of parents.
- Patient sensitivity to any of the study medications.
- Known neurological disease that can affect the assessment of ED postoperatively.
Key Trial Info
Start Date :
August 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 10 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06545890
Start Date
August 10 2024
End Date
November 10 2024
Last Update
August 20 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Abu Elresh Hospitals ( Cairo university )
Cairo, Egypt
2
Abu ElResh hospital
Cairo, Egypt